NS-EN 45502-2-2:2008
有源植入式医疗器械 第2-2部分:用于治疗快速心律失常的有源植入式医疗器械(包括植入式除颤器)的特殊要求

Active implantable medical devices - Part 2-2: Particular requirements for active implantable medical devices intended to treat tachyarrhythmia (includes implantable defibrillators)


 

 

非常抱歉,我们暂时无法提供预览,您可以试试: 免费下载 NS-EN 45502-2-2:2008 前三页,或者稍后再访问。

您也可以尝试购买此标准,
点击右侧 “立即购买” 按钮开始采购(由第三方提供)。

 

标准号
NS-EN 45502-2-2:2008
发布
2015年
发布单位
SCC
当前最新
NS-EN 45502-2-2:2008
 
 
适用范围
  Full Description ADOPTED_FROM:EN 45502-2-2:2008 This Part 2-2 of EN 45502 specifies requirements that are applicable to IMPLANTABLE CARDIOVERTER DEFIBRILLATORS and the functions of ACTIVE IMPLANTABLE MEDICAL DEVICES intended to treat tachyarrhythmia. The tests that are specified in EN 45502 are type tests and are to be carried out on samples of a device to show compliance. This part of EN 45502 is also applicable to some non-implantable parts and accessories of the devices (see Note 1). The characteristics of the IMPLANTABLE PULSE GENERATOR or LEAD shall be determined by either the appropriate method detailed in this particular standard or by any other method demonstrated to have accuracy equal to, or better than, the method specified. In the case of dispute, the method detailed in this Particular Standard shall apply. Any aspect of an ACTIVE IMPLANTABLE MEDICAL DEVICE intended to treat bradyarrhythmias is covered by EN 45502–2-1 Particular requirements for active implantable medical devices intended to treat bradyarrhythmia (Pacemakers). NOTE 1 The device that is commonly referred to as an ACTIVE IMPLANTABLE MEDICAL DEVICE may in fact be a single device, a combination of devices, or a combination of a device or devices and one or more accessories. Not all of these parts are required to be either partially or totally implantable, but there is a need to specify some requirements of non-implantable parts and accessories if they could affect the safety or performance of the implantable device. NOTE 2 The terminology used in this European Standard is intended to be consistent with the terminology of Directive 90/385/EEC. NOTE 3 In this European Standard, terms printed in small capital letters are used as defined in Clause 3. Where a defined term is used as a qualifier in another term, it is not printed in small capital letters unless the concept thus qualified is also defined. NOTE 4 Particular requirements for congestive heart failure devices are under consideration. These types of devices are not covered by this standard.

NS-EN 45502-2-2:2008相似标准


推荐

186项医疗器械行业标准已出炉(附名单)

》35YY 0592—2016《高强度聚焦超声(HIFU)治疗系统》36YY 0605.12—2016《外科植入物金属材料12部分:锻造钴-铬-钼合金》37YY 0621.1—2016《牙科学匹配性试验1部分:金属-陶瓷体系》38YY 0803.3—2016《牙科学根管器械3部分加压》39YY  0989.6—2016《手术植入有源植入医疗器械6部分治疗快速心律失常有源植入医疗器械...

CFDA:新版《医疗器械分类规则》发布,2016年起实施

修改后,本《规则》中植入器械”是指,“借助手术全部或者部分进入人体内或腔道(口)中,或者用于替代人体上皮表面或眼表面,并且在手术过程结束后留在人体内30日(含)以上或者被人体吸收医疗器械。”因此,该定义明确了植入器械必须同时符合两个条件,一是符合规定植入位置”,二是符合规定植入时间”,植入时间既包括留在人体内30日以上,也包括被人体吸收情形。...

医疗器械注册审评流程之医疗器械临床评价

该目录包含8类医疗器械,分别为采用全新设计/用于全新适用范围植入心脏起搏植入心脏植入心脏再同步复律;采用全新设计/用于全新适用范围植入血泵;采用全新设计/用于全新适用范围植入药物灌注泵;境内市场上尚未出现血管内支架系统;境内市场上尚未出现植入性人工器官、接触人工器官、骨科内固定产品及骨科填充材料;可吸收四肢长骨内固定产品;纳米骨科植入物;定制增材制造(3D打印...

FDA 开发免疫分析和动物模型评估疫苗对疾病安全有效性

指南涵盖了药物(化学、生物或放射性药物)管理、给药或使用所必需设备,可以是一体式产品,例如预充注射和自动注射,或非一体式产品,例如器械与药物共同包装或药物和器械分开供应情况。  使用机电设备(包括有源植入设备)、电子插件和器械数字元素医药产品也在指南范围内,这些器械部分预期会影响或可能影响药品质量方面的获益风险评价。这方面,EMA 承认未来可能需要更详细指南。  ...





Copyright ©2007-2022 ANTPEDIA, All Rights Reserved
京ICP备07018254号 京公网安备1101085018 电信与信息服务业务经营许可证:京ICP证110310号